US subsidiary Taro Pharma in its annual general meeting notice says it has withdrawn proposal worth USD 225 million to invest in wind energy business.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
US subsidiary Taro Pharma in its annual general meeting notice says it has withdrawn proposal worth USD 225 million to invest in wind energy business.
| Subscribe To Our Free Newsletter |
